Pancreatic Cancer Research

ResearcherKorea Advanced Institute of Science and TechnologyActive in the last 2 years

Dae‐Sik Lim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2356-7555; OpenAlex author ID A5038114229. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. Last author DOI 10.1016/j.xcrm.2024.101461↗
  2. YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice. Last author DOI 10.1158/0008-5472.can-20-0907↗
  3. Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells. Last author DOI 10.1371/journal.pone.0078130↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunhee Kim · 1 shared paper, 2024 · strength 0.18
  2. Bomin Ku · 1 shared paper, 2024 · strength 0.18
  3. Sun‐Young Kong · 1 shared paper, 2024 · strength 0.18
  4. Sang Myung Woo · 1 shared paper, 2024 · strength 0.18
  5. Jaeoh Park · 1 shared paper, 2020 · strength 0.13
  6. Sang Kyum Kim · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.